HC
MRNA icon

Hurley Capital’s Moderna MRNA Stock Holding History

Hurley Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48K Hold
64
– – ﹤0.01% 461
2026
Q1 		$3.25K Hold
64
– – ﹤0.01% 515
2025
Q4 		$1.89K Sell
64
-103
-62% -$2.8K ﹤0.01% 507
2025
Q3 		$4.31K Hold
167
– – ﹤0.01% 465
2025
Q2 		$4.61K Hold
167
– – ﹤0.01% 372
2025
Q1 		$4.73K Hold
167
– – ﹤0.01% 379
2024
Q4 		$7.25K Buy
+167
New +$7.98K 0.01% 312

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Hurley Capital's MRNA Position: Q2 2026 in Review

Hurley Capital held its Moderna (MRNA) position steady in Q2 2026 at 64 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Hurley Capital first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.25K in Q4 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Hurley Capital held 64 shares of Moderna worth $4.48K as of Q2 2026.
  • Hurley Capital left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #461 holding.
  • Hurley Capital first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's Moderna position peaked at $7.25K in Q4 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.